PEPTONIC MEDICAL (28L) - Total Assets
Based on the latest financial reports, PEPTONIC MEDICAL (28L) holds total assets worth €60.76 Million EUR (≈ $71.04 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PEPTONIC MEDICAL - Total Assets Trend (2021–2025)
This chart illustrates how PEPTONIC MEDICAL's total assets have evolved over time, based on quarterly financial data. Also see 28L market cap for the company's overall valuation and market capitalisation.
PEPTONIC MEDICAL - Asset Composition Analysis
Current Asset Composition (December 2025)
PEPTONIC MEDICAL's total assets of €60.76 Million consist of 20.7% current assets and 79.3% non-current assets. Review 28L liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0.3% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €5.62 Million | 8.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €48.66 Million | 73.8% |
| Goodwill | €3.30 Million | 5.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how PEPTONIC MEDICAL's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 28L share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PEPTONIC MEDICAL's current assets represent 20.7% of total assets in 2025, a decrease from 33.3% in 2021.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2025, down from 12.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 78.0% of total assets, an increase from 61.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 73.8% of total assets.
PEPTONIC MEDICAL Competitors by Total Assets
Key competitors of PEPTONIC MEDICAL based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
PEPTONIC MEDICAL - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.85 | 0.82 | 1.76 |
| Quick Ratio | 0.40 | 0.64 | 1.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-1.74 Million | €-4.63 Million | €11.71 Million |
PEPTONIC MEDICAL - Advanced Valuation Insights
This section examines the relationship between PEPTONIC MEDICAL's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.23 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | -6.6% |
| Total Assets | €65.92 Million |
| Market Capitalization | $5.52 Million USD |
Valuation Analysis
Below Book Valuation: The market values PEPTONIC MEDICAL's assets below their book value (0.08x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: PEPTONIC MEDICAL's assets decreased by 6.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for PEPTONIC MEDICAL (2021–2025)
The table below shows the annual total assets of PEPTONIC MEDICAL from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €65.92 Million ≈ $77.06 Million |
-6.58% |
| 2024-12-31 | €70.56 Million ≈ $82.49 Million |
-33.89% |
| 2023-12-31 | €106.74 Million ≈ $124.79 Million |
+24.47% |
| 2022-12-31 | €85.75 Million ≈ $100.25 Million |
+1.36% |
| 2021-12-31 | €84.60 Million ≈ $98.91 Million |
-- |
About PEPTONIC MEDICAL
PEPTONIC medical AB (publ), a medical technology company, develops and sells intimate self-care products for women. The company offers products under the VagiVital brand, including a moisturizing gel for atrophy; an intimate calming gel for rapid relief of itching and irritation; moisturizing lubricant; a pH-balancing intimate wash/conditioner; self-test kits for diagnosing pre-menopause, menopau… Read more